Huanying Y. Zheng
No. 176, Xingangxi Road
Guangzhou, 510300, China
Guangzhou, 510300, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Construction of a Suckling Mouse Model Based on an EV-C96 Clinical Isolate and Its Application in Drug Screening and Vaccine Development.
Journal: Antiviral research
Published: April 15, 2026
Single-dose infusion of engineered viral receptor binding domain confers rapid and durable protection against viral infection.
Journal: Communications biology
Published: December 01, 2024
Establishment and application of a wild neonatal mouse model infected with an Echovirus 30 isolate.
Journal: Virology journal
Published: October 23, 2024
Serological investigation on the prevalence of poliovirus in Guangdong province: A cross-sectional study.
Journal: Human vaccines & immunotherapeutics
Published: January 08, 2024
Human angiotensin-converting enzyme 2-specific antisense oligonucleotides reduce infection with SARS-CoV-2 variants.
Journal: The Journal of allergy and clinical immunology
Published: October 22, 2023
Prevalence of Non-Polio Enteroviruses in the Sewage of Guangzhou City, China, from 2013 to 2021.
Journal: Microbiology spectrum
Published: March 30, 2023
A comparative study on environmental surveillance of enterovirus: Using a two-phase separation method and a filtration method with a mixed cellulose ester (MCE) membrane.
Journal: Biosafety and health
Published: December 20, 2022
Dynamic changes in polioviruses identified by environmental surveillance in Guangzhou, 2009-2021.
Journal: Journal of medical virology
Published: December 02, 2022
Identification of a neutralizing linear epitope within the VP1 protein of coxsackievirus A10.
Journal: Virology journal
Published: September 14, 2022
Human Fc-Conjugated Receptor Binding Domain-Based Recombinant Subunit Vaccines with Short Linker Induce Potent Neutralizing Antibodies against Multiple SARS-CoV-2 Variants.
Journal: Vaccines
Published: August 11, 2022
The adenosine analog prodrug ATV006 is orally bioavailable and has preclinical efficacy against parental SARS-CoV-2 and variants.
Journal: Science translational medicine
Published: May 17, 2022
Last Updated: 09/26/2026